Funding

Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 2003; 290(7):921-928.
PMID: 12928469

Barden J, Derry S, Mcquay HJ, Moore RA. Bias from industry trial funding? A framework, a suggested approach, and a negative result. Pain 2006; 121(3):207-218.
PMID: 16495012 

Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003; 289(4):454-465.
PMID: 12533125

Bero L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Med 2007; 4(6):e184.
PMID: 17550302 

Bero LA, Rennie D. Influences on the quality of published drug studies. Int J Technol Assess Health Care 1996; 12(2):209-237.
PMID: 8707496

Brown A, Kraft D, Schmitz SM, Sharpless V, Martin C, Shah R, Shaheen NJ. Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Clin Gastroenterol Hepatol 2006; 4(12):1445-1451.
PMID: 17101295 

Chalmers I, Rounding C, Lock K. Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002. BMJ 2003; 327(7422):1017.
PMID: 14593034 

Clifford TJ, Moher D, Barrowman N. Absence of associations between funding source, trial outcome, and quality score: a benefit of financial disclosure? 4th International Congress on Peer Review in Biomedical Publication, September 14 16, 2001 in Barcelona, Spain 2001.

Davidoff F, DeAngelis CD, Drazen JM, Hoey J, Hojgaard L, Horton R, Kotzin S, Nicholls MG, Nylenna M, Overbeke AJ, Sox HC, Van Der Weyden MB, Wilkes MS. Sponsorship, authorship, and accountability. JAMA 2001; 286(10):1232-1234.
PMID: 11559271 
[New]

DeAngelis CD, Fontanarosa PB. Impugning the integrity of medical science: the adverse effects of industry influence. JAMA 2008; 299(15):1833-1835.
PMID: 18413880
[New]

Decullier E, Chapuis F. Impact of funding on biomedical research: a retrospective cohort study. BMC Public Health 2006; 6:165.
PMID: 16792794 

Etter JF, Burri M, Stapleton J. The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta-analysis. Addiction 2007; 102(5):815-822.
PMID: 17493109 

Gøtzsche PC, Hrobjartsson A, Johansen HK, Haahr MT, Altman DG, Chan AW. Constraints on publication rights in industry-initiated clinical trials. JAMA 2006; 295(14):1645-1646.
PMID: 16609085 

Jørgensen AW, Hilden J, Gøtzsche PC. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 2006; 333(7572):782.
PMID: 17028106 

Kjaergard LL, Gluud C. Funding, disease area, and internal validity of hepatobiliary randomized clinical trials. Am J Gastroenterol 2002; 97(11):2708-2713.
PMID: 12425537

Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS. Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med 2007; 4(1):e5.
PMID: 17214504 

Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326(7400):1167-1170.
PMID: 12775614 

Liss H. Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship. Isr Med Assoc J 2006; 8(7):451-454.
PMID: 16889157 

Melander H, hlqvist-Rastad J, Meijer G, Beermann B. Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 2003; 326(7400):1171-1173.
PMID: 12775615 

Moja PL, Moschetti I, D'Amico R. Outcome reporting bias in government-funded RCTs. CMAJ 2005; 172(7):857.
PMID: 15795393 

Montgomery JH, Byerly M, Carmody T, Li B, Miller DR, Varghese F, Holland R. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia. Control Clin Trials 2004; 25(6):598-612.
PMID: 15588746 

Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, Nierenberg AA. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 2005; 162(10):1957-1960.
PMID: 16199844 

Ridker PM, Torres J. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005. JAMA 2006; 295(19):2270-2274.
PMID: 16705108

Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA 2008; 299(15):1800-1812.
PMID: 18413874  [New]

Safer DJ. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. J Nerv Ment Dis 2002; 190(9):583-592.
PMID: 12357091 

Scharf O, Colevas AD. Adverse event reporting in publications compared with sponsor database for cancer clinical trials. J Clin Oncol 2006; 24(24):3933-3938.
PMID: 16921045 

Shah RV, Albert TJ, Bruegel-Sanchez V, Vaccaro AR, Hilibrand AS, Grauer JN. Industry support and correlation to study outcome for papers published in Spine. Spine 2005; 30(9):1099-1104.
PMID: 15864166 

Thomas O, Thabane L, Douketis J, Chu R, Westfall AO, Allison DB. Industry funding and the reporting quality of large long-term weight loss trials. Int J Obes (Lond) 2008;
PMID: 18711388  [New]

Tuech JJ, Moutel G, Pessaux P, Thoma V, Schraub S, Herve C. Disclosure of competing financial interests and role of sponsors in phase III cancer trials. Eur J Cancer 2005; 41(15):2237-2240.
PMID: 16214044 

Tulikangas PK, Ayers A, O'Sullivan DM. A meta-analysis comparing trials of antimuscarinic medications funded by industry or not. BJU Int 2006; 98(2):377-380.
PMID: 16879680

Wahlbeck K, Adams C. Beyond conflict of interest. Sponsored drug trials show more-favourable outcomes. BMJ 1999; 318(7181):465.
PMID: 10084842 

Yaphe J, Edman R, Knishkowy B, Herman J. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract 2001; 18(6):565-568.
PMID: 11739337 

 

Page last edited: 06 May 2009